Page 130 - 《中国药房》2024年12期
P. 130

[ 4 ]  中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会                     [13]  胡志强,余文韬,姚文秀,等. 抗肿瘤药物致心脏毒性及
              (CSCO)乳腺癌诊断和治疗指南 2022[M]. 北京:人民健                     其防治措施的研究进展[J]. 中国药房,2020,31(2):
               康出版社,2022:95-103.                                   250-256.
               Guidelines Working Committee of the Chinese Society of   HU Z Q,YU W T,YAO W X,et al. Research progress on
               Clinical Oncology. Chinese Society of Clinical Oncology  cardiotoxicity caused by antineoplastic drugs and its pre‐
              (CSCO)guidelines  for  the  diagnosis  and  treatment  of   vention and treatment measures[J]. China Pharm,2020,31
               breast  cancer  2022[M].  Beijing:People’s  Health  Publi-  (2):250-256.
               shing House,2022:95-103.                       [14]  O’BRIEN M E R,WIGLER N,INBAR M,et al. Reduced
          [ 5 ]  张剑 . 中国蒽环类药物治疗乳腺癌专家共识[J]. 癌症,                     cardiotoxicity and comparable efficacy in a phase Ⅲ trial
               2021,40(11):475-485.                                of pegylated liposomal doxorubicin HCl(CAELYX/Doxil)
               ZHANG J. Expert consensus of anthracycline drugs in the   versus conventional doxorubicin for first-line treatment of
               treatment  of  breast  cancer  in  China[J].  Chin  J  Cancer,  metastatic  breast  cancer[J].  Ann  Oncol,2004,15(3):
               2021,40(11):475-485.                                440-449.
          [ 6 ]  LOTRIONTE  M,BIONDI-ZOCCAI  G,ABBATE  A,et   [15]  CHEN  S,WU  F,HAI  R,et  al. Thyroid  disease  is  asso-
               al. Review and meta-analysis of incidence and clinical pre‐  ciated with an increased risk of breast cancer:a systematic
               dictors  of  anthracycline  cardiotoxicity[J]. Am  J  Cardiol,  review  and  meta-analysis[J].  Gland  Surg,2021,10(1):
               2013,112(12):1980-1984.                             336-346.
          [ 7 ]  RENEHAN A G,HARVIE M,CUTRESS R I,et al. How   [16]  岑福俊,杨剑波. 乳腺癌患者甲状腺激素和自身抗体的
               to manage the obese patient with cancer[J]. J Clin Oncol,  水平及临床意义[J]. 癌症进展,2019,17(18):2180-
               2016,34(35):4284-4294.                              2182,2191.
          [ 8 ]  MICHEL L,MINCU R I,MAHABADI A A,et al. Tropo‐     CEN F J,YANG J B. The levels and clinical significance
               nins and brain natriuretic peptides for the prediction of car‐  of thyroid hormone and autoantibody in breast cancer pa‐
               diotoxicity  in  cancer  patients:a  meta-analysis[J].  Eur  J   tients[J]. Oncol Prog,2019,17(18):2180-2182,2191.
               Heart Fail,2020,22(2):350-361.                 [17]  KLEIN  HESSELINK  E  N,KLEIN  HESSELINK  M  S,
          [ 9 ]  ROBERT J,MORVAN V L,SMITH D,et al. Predicting     DE BOCK G H,et al. Long-term cardiovascular mortality
               drug response and toxicity based on gene polymorphisms  in patients with differentiated thyroid carcinoma:an obser‐
               [J]. Crit Rev Oncol Hematol,2005,54(3):171-196.     vational study[J]. J Clin Oncol,2013,31(32):4046-4053.
          [10]  MACEDO A V S,HAJJAR L A,LYON A R,et al. Effi‐  [18]  LIM H J,AHN S H,HONG S,et al. The relationship be‐
               cacy  of  dexrazoxane  in  preventing  anthracycline  cardio‐  tween  subclinical  thyroid  disease  and  cardiovascular  di-
               toxicity in breast cancer[J]. JACC Cardio Oncol,2019,1  sease risk score in Koreans[J]. J Korean Med Sci,2017,32
              (1):68-79.                                          (10):1626-1632.
          [11]  CORREMANS R,ADÃO R,DE KEULENAER G W,et        [19]  HAUGEN B R,ALEXANDER E K,BIBLE K C,et al.
               al.  Update  on  pathophysiology  and  preventive  strategies   2015 American  Thyroid Association  management  guide‐
               of anthracycline-induced cardiotoxicity[J]. Clin Exp Phar‐  lines for adult patients with thyroid nodules and differen-
               macol Physiol,2019,46(3):204-215.                   tiated  thyroid  cancer:the  American  Thyroid  Association
          [12]  LIPSHULTZ  S  E,GIANTRIS A  L,LIPSITZ  S  R,et  al.   guidelines task force on thyroid nodules and differentiated
               Doxorubicin administration by continuous infusion is not   thyroid cancer[J]. Thyroid,2016,26(1):1-133.
               cardioprotective:the  Dana-Farber  91-01  acute  lympho‐     (收稿日期:2023-12-18  修回日期:2024-05-11)
               blastic leukemia protocol[J]. J Clin Oncol,2002,20(6):                             (编辑:孙 冰)
               1677-1682.














          · 1532 ·    China Pharmacy  2024 Vol. 35  No. 12                            中国药房  2024年第35卷第12期
   125   126   127   128   129   130   131   132   133   134   135